QQQ   290.88 (+0.17%)
AAPL   113.48 (-0.32%)
MSFT   209.25 (-0.41%)
FB   271.09 (+0.99%)
GOOGL   1,730.39 (+0.16%)
AMZN   3,106.16 (+0.25%)
TSLA   537.00 (+2.90%)
NVDA   519.22 (-1.21%)
BABA   275.29 (+1.92%)
CGC   27.05 (+9.43%)
GE   10.67 (+5.96%)
MU   63.18 (-1.56%)
AMD   83.74 (-1.84%)
T   29.19 (+1.99%)
NIO   53.63 (-3.16%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   479.49 (+0.60%)
GILD   60.05 (+0.27%)
BA   220.42 (+4.20%)
DIS   149.21 (+2.21%)
QQQ   290.88 (+0.17%)
AAPL   113.48 (-0.32%)
MSFT   209.25 (-0.41%)
FB   271.09 (+0.99%)
GOOGL   1,730.39 (+0.16%)
AMZN   3,106.16 (+0.25%)
TSLA   537.00 (+2.90%)
NVDA   519.22 (-1.21%)
BABA   275.29 (+1.92%)
CGC   27.05 (+9.43%)
GE   10.67 (+5.96%)
MU   63.18 (-1.56%)
AMD   83.74 (-1.84%)
T   29.19 (+1.99%)
NIO   53.63 (-3.16%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   479.49 (+0.60%)
GILD   60.05 (+0.27%)
BA   220.42 (+4.20%)
DIS   149.21 (+2.21%)
QQQ   290.88 (+0.17%)
AAPL   113.48 (-0.32%)
MSFT   209.25 (-0.41%)
FB   271.09 (+0.99%)
GOOGL   1,730.39 (+0.16%)
AMZN   3,106.16 (+0.25%)
TSLA   537.00 (+2.90%)
NVDA   519.22 (-1.21%)
BABA   275.29 (+1.92%)
CGC   27.05 (+9.43%)
GE   10.67 (+5.96%)
MU   63.18 (-1.56%)
AMD   83.74 (-1.84%)
T   29.19 (+1.99%)
NIO   53.63 (-3.16%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   479.49 (+0.60%)
GILD   60.05 (+0.27%)
BA   220.42 (+4.20%)
DIS   149.21 (+2.21%)
QQQ   290.88 (+0.17%)
AAPL   113.48 (-0.32%)
MSFT   209.25 (-0.41%)
FB   271.09 (+0.99%)
GOOGL   1,730.39 (+0.16%)
AMZN   3,106.16 (+0.25%)
TSLA   537.00 (+2.90%)
NVDA   519.22 (-1.21%)
BABA   275.29 (+1.92%)
CGC   27.05 (+9.43%)
GE   10.67 (+5.96%)
MU   63.18 (-1.56%)
AMD   83.74 (-1.84%)
T   29.19 (+1.99%)
NIO   53.63 (-3.16%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   479.49 (+0.60%)
GILD   60.05 (+0.27%)
BA   220.42 (+4.20%)
DIS   149.21 (+2.21%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 DaVitaProgynyOntrakTivity HealthAmerican Renal Associates
SymbolNYSE:DVANASDAQ:PGNYNASDAQ:OTRKNASDAQ:TVTYNYSE:ARA
Price Information
Current Price$109.67$33.83$49.77$17.71$11.44
52 Week RangeHoldBuyBuyBuyHold
Beat the Market™ Rank
Overall Score1.81.50.01.61.0
Analysis Score1.21.40.02.31.0
Community Score2.33.50.02.32.3
Dividend Score0.00.00.00.00.0
Ownership Score1.70.80.01.71.7
Earnings & Valuation Score3.81.90.01.90.0
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price Target$77.50$34.43$81.40$20.25$8.67
% Upside from Price Target-29.33% downside1.77% upside63.55% upside14.34% upside-24.24% downside
Trade Information
Market Cap$12.32 billion$2.79 billion$896.92 million$856.68 million$394.21 million
Beta1.18N/A2.582.331.23
Average Volume1,234,470772,968467,2941,128,150112,153
Sales & Book Value
Annual Revenue$11.39 billion$229.68 million$35.10 million$1.13 billion$822.52 million
Price / Sales1.0812.7624.690.760.48
Cashflow$10.93 per share$0.17 per shareN/A$3.61 per share$1.69 per share
Price / Cash10.03197.37N/A4.906.77
Book Value$15.65 per share$1.36 per share($1.44) per share$4.73 per share$2.07 per share
Price / Book7.0124.88-34.563.745.53
Profitability
Net Income$810.98 million$-8,570,000.00$-25,660,000.00$-286,820,000.00$-13,790,000.00
EPS$5.40$0.11($1.15)$2.02$0.26
Trailing P/E Ratio16.44N/AN/AN/AN/A
Forward P/E Ratio13.3189.03N/A10.80N/A
P/E Growth0.83N/AN/A1.10N/A
Net Margins7.32%-3.81%-61.90%-40.68%-2.04%
Return on Equity (ROE)43.99%10.04%N/A36.30%-3.56%
Return on Assets (ROA)5.27%4.56%-107.02%4.58%-0.24%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio4.49%N/AN/A26.60%7.54%
Current Ratio1.37%2.77%1.14%0.96%1.05%
Quick Ratio1.33%2.77%1.14%0.81%1.02%
Ownership Information
Institutional Ownership Percentage95.27%54.09%24.65%99.21%77.87%
Insider Ownership Percentage1.00%33.30%58.20%11.77%9.50%
Miscellaneous
Employees65,0001673951,0004,977
Shares Outstanding112.00 million86.63 million17.42 million48.62 million34.52 million
Next Earnings Date2/8/2021 (Estimated)3/4/2021 (Estimated)3/11/2021 (Estimated)2/17/2021 (Estimated)3/15/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.